These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18026234)

  • 1. [Patients, patents and profits].
    Haug C
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2921. PubMed ID: 18026234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Patients, patents and profits].
    Roland PC
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug industry's misuse of patents must be prevented].
    Magnusson PA
    Lakartidningen; 2008 Feb 20-26; 105(8):555. PubMed ID: 18363299
    [No Abstract]   [Full Text] [Related]  

  • 4. [From orthoclone to denosumab, the fast growing market of monoclonal antibodies].
    Biot J; Fasano C; Dos Santos C
    Med Sci (Paris); 2009 Dec; 25(12):1177-82. PubMed ID: 20035702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach to drug development.
    Brown S
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948
    [No Abstract]   [Full Text] [Related]  

  • 6. The London Agreement and the future of parallel imports.
    Muir J
    Nat Biotechnol; 2008 Aug; 26(8):877-9. PubMed ID: 18688237
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug industry in India is threatened by free trade agreement].
    Jeppsson A
    Lakartidningen; 2009 Oct 7-13; 106(41):2589. PubMed ID: 19927922
    [No Abstract]   [Full Text] [Related]  

  • 8. A new approach to drug development.
    Frangioni JV
    N Engl J Med; 2006 Nov; 355(19):2046; author reply 2046. PubMed ID: 17099947
    [No Abstract]   [Full Text] [Related]  

  • 9. Brand-name drug companies fail to meet R&D commitments.
    Kondro W
    CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical innovation and patent gridlock.
    James JS
    AIDS Treat News; 2005 May; (412):6-8. PubMed ID: 16050004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J
    Science; 2007 May; 316(5826):816. PubMed ID: 17495145
    [No Abstract]   [Full Text] [Related]  

  • 12. [The patent is "engine" in drug development].
    Bergström R
    Lakartidningen; 2008 Mar 5-11; 105(10):752. PubMed ID: 18422246
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug companies face pressure on profits.
    Josefson D
    BMJ; 2002 Jan; 324(7329):65. PubMed ID: 11786439
    [No Abstract]   [Full Text] [Related]  

  • 14. Genentech relaunched with independence intact.
    Glaser V
    Nat Biotechnol; 1999 Jul; 17(7):634. PubMed ID: 10409348
    [No Abstract]   [Full Text] [Related]  

  • 15. Trip into the unknown.
    Anderson T
    Nature; 2007 Nov; 450(7169):471. PubMed ID: 18033269
    [No Abstract]   [Full Text] [Related]  

  • 16. How much is more life worth?
    Brock DW
    Hastings Cent Rep; 2006; 36(3):17-9. PubMed ID: 16776018
    [No Abstract]   [Full Text] [Related]  

  • 17. The art of mismanagement.
    Nat Biotechnol; 2006 Nov; 24(11):1300. PubMed ID: 17093455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical pharmaceuticals and distributive justice.
    Boylan M
    Camb Q Healthc Ethics; 2008; 17(1):30-44. PubMed ID: 18462543
    [No Abstract]   [Full Text] [Related]  

  • 19. The Health Impact Fund: boosting pharmaceutical innovation without obstructing free access.
    Pogge T
    Camb Q Healthc Ethics; 2009; 18(1):78-86. PubMed ID: 19091149
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent-drug price board to review guidelines.
    Sibbald B
    CMAJ; 2005 Apr; 172(9):1169. PubMed ID: 15851703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.